The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Oxidative and nitrosative stress in Parkinson's disease
Open accessAbstract
Parkinson's disease (PD) is a common neurodegenerative disorder marked by movement impairment caused by a selective degeneration of dopaminergic neurons. The mechanism for dopaminergic neuronal degeneration in PD is not completely clear, but it is believed that oxidative and nitrosative stress plays an important role during the pathogenesis of PD. This notion is supported by various studies that several indices of oxidative and nitrosative stress are increased in PD patients. In recent years, different pathways that are known to be important for neuronal survival have been shown to be affected by oxidative and nitrosative stress. Apart from the well-known oxidative free radicals induced protein nitration, lipid peroxidation and DNA damage, increasing evidence also suggests that some neuroprotective pathways can be affected by nitric oxide through S-nitrosylation. In addition, the selective dopaminergic neurodegeneration suggests that generation of oxidative stress associated with the metabolism of dopamine is an important contributor. Thorough understanding of how oxidative stress can contribute to the pathogenesis of PD will help formulate potential therapy for the treatment of this neurodegenerative disorder in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Caspase 3-S-nitrosation is antiapoptotic as it inhibits the activation of this effector caspase (424).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [424]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Reconciling the chemistry and biology of reactive oxygen species
Winterbourn, C. C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.85 · Cited by 2,504
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Cited by
Sorted by citations
Items 201–300 of 302
Cyclic Peptides in Neurological Disorders: The Case of Cyclo(His-Pro)
Bellezza, I., Peirce, M. J., & Minelli, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814905-8.00010-1 · Cited by 13
Tharwat, E. K., Abdelaty, A., Abdelrahman, A. I., Elsaeed, H., Elgohary, A., El-Feky, A. S., Ebrahim, Y. M., Sakraan, A., Ismail, H. A., Khadrawy, Y. A., et al. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01189-4 · Cited by 11
Ali, I., Adil, M., Imran, M., Qureshi, S. A., Qureshi, S., Hasan, N., & Ahmad, F. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01799-8 · Cited by 11
Cortina‐Puig, M., Scangas, A. C. H., Marchese, Z. S., Andreescu, S., Marty, J., & Calas‐Blanchard, C. (2010) · Electroanalysis · doi:10.1002/elan.201000248 · Cited by 11
Zhu, J., Hannan, S. B., Dräger, N. M., Vereshchagina, N., Krahl, A.-C., Fu, Y., Elliott, C. J. H., Han, Z., Jahn, T. R., & Rasse, T. M. (2021) · Autophagy · doi:10.1080/15548627.2020.1871211 · Cited by 10
Proteomic analysis of S-nitrosylation induced by 1-methyl-4-phenylpyridinium (MPP+)
Komatsubara, A. T., Asano, T., Tsumoto, H., Shimizu, K., Nishiuchi, T., Yoshizumi, M., & Ozawa, K. (2012) · Proteome Science · doi:10.1186/1477-5956-10-74 · Cited by 11
Nemati, M., Hemmati, A. A., Najafzadeh, H., Mansouri, M. T., & Khodayar, M. J. (2018) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp.67391 · Cited by 11
Pereira, A. G., Poli, A., MATHEUS, F. C., da Silva, L. D. B., Fadanni, G. P., Izídio, G. S., Latini, A., & Prediger, R. D. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112517 · Cited by 11
Kan, J., Huang, H., Jiang, Z., Zhou, R.-S., Bai, S., Liao, C., Chen, J., Dong, J., Zhang, Y., Zhang, J., et al. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8909171 · Cited by 11
Rafeiy-Torghabeh, M., Ashraf‐Ganjouei, A., Moradi, K., Bagheri, S., Mohammadi, M.-R., & Akhondzadeh, S. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01562-z · Cited by 10
Modulation of pro-survival proteins by S-nitrosylation: implications for neurodegeneration
Chung, K. K. K. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0464-1 · Cited by 10
Self-citationJiang, P., Huang, P., Yen, S.-H. C., Zubair, A. C., & Dickson, D. W. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.08.008 · Cited by 10
Ayed‐Boussema, I., Hamdi, H., Chaabani, H., M’nassri, A., Mokni, M., & Abid, S. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.05.009 · Cited by 10
Leads from xenobiotic metabolism genes for Parkinson’s disease among north Indians
Punia, S., Das, M., Behari, M., Dihana, M., Govindappa, S. T., Muthane, U. B., Thelma, B. K., & Juyal, R. C. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834bcd74 · Cited by 9
Hyon, J., Lee, H. J., Yun, S. H., Han, E. H., & Chung, Y. (2023) · Journal of Analytical Science & Technology · doi:10.1186/s40543-022-00365-y · Cited by 9
The Key Role of Membranes in Amyloid Formation from a Biophysical Perspective
Torres-Bugeau, C. M., Borsarelli, C. D., Minahk, C. J., & Chehín, R. N. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795860197 · Cited by 9
Toader, A. M., Filip, G. A., Decea, N., & Mureșan, A. (2013) · Europe PMC (PubMed Central) · Cited by 9
Studying Nitrosative Stress in Parkinson’s Disease
Chung, K. K. K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2522-3_14 · Cited by 9
Self-citationSofiabadi, M., Rastgoo, N., & Haghdoost-Yazdi, H. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-03012-6 · Cited by 8
RetractedTranslating Pathological Brain Activity Primers in Parkinson’s Disease Research
Mîrzac, D., Kreis, S. L., Luhmann, H. J., González‐Escamilla, G., & Groppa, S. (2023) · Research · doi:10.34133/research.0183 · Cited by 8
Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression
Abdelaty, A., Tharwat, E. K., Abdelrahman, A. I., Elgohary, A., Elsaeed, H., El-Feky, A. S., Ebrahim, Y. M., Habib, A., Latif, H. A. E., Khadrawy, Y. A., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.02.029 · Cited by 8
The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases
Rocha, K. M. A., Goulart, A. D. S., Costa, M. T., Salgueiro, A. C. F., & Folmer, V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11673 · Cited by 9
Stanković, D. M., Mehmeti, E., Švorc, Ĺ., & Kalcher, K. (2015) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)05086-1 · Cited by 8
Partial Protection of PC12 Cells from Cellular Stress by Low-Dose Sodium Nitroprusside Pre-treatment
Varga, J., Bátor, J., Nádasdi, G., Árvai, Z., Schipp, R., & Szeberényi, J. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0312-5 · Cited by 7
Molinero, G. D. M., Boldrini, G. G., Chaca, M. V. P., Moyano, M. F., Armonelli, S., Giménez, M. S., Gómez, N. N., López, P. H. H., & Álvarez, S. M. (2022) · BioMetals · doi:10.1007/s10534-022-00462-w · Cited by 7
Yoko, A., & Michael, A. (2013) · InTech eBooks · doi:10.5772/54653 · Cited by 7
Does Concurrent Use of Some Botanicals Interfere with Treatment of Tuberculosis?
Folk, W. R., Smith, A., Song, H., Chuang, D. Y., Cheng, J. J., Gu, Z., & Sun, G. Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8402-1 · Cited by 7
Kriss, C. L., Duro, N. D., Nadeau, O. W., Guergues, J., Chiang, O. C., Culver‐Cochran, A. E., Chaput, D., Varma, S., & Stevens, S. M. (2021) · Journal of Mass Spectrometry · doi:10.1002/jms.4713 · Cited by 7
Etiology and pathogenesis of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 8
Introduction and Perspectives on the Chemistry and Biology of DNA Damage
Geacintov, N. E., & Broyde, S. B. (2010) · Wiley eBooks · doi:10.1002/9783527630110.ch1 · Cited by 7
Neuroprotective Properties of Dietary Polyphenols in Parkinson's Disease
Darvesh, A. S., McClure, M., Sadana, P., Paxos, C., Geldenhuys, W. J., Lambert, J. D., Haqqi, T. M., & Richardson, J. R. (2017) · doi:10.1002/9781119155195.ch11 · Cited by 7
Arianti, D., Novera, M., & rosa, A. Y. (2017) · JIK JURNAL ILMU KESEHATAN · doi:10.33757/jik.v1i1.29 · Cited by 6
Setzu, M. D., Mocci, I., Fabbri, D., Carta, P., Muroni, P., Diana, A., Dettori, M. A., & Casu, M. A. (2024) · Biomolecules · doi:10.3390/biom14030273 · Cited by 5
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-19683-6_2 · Cited by 6
Pozzi, N. G., Bolzoni, F., Biella, G. E. M., Pezzoli, G., Ip, C. W., Volkmann, J., Cavallari, P., Asan, E., & Isaias, I. U. (2023) · Cells · doi:10.3390/cells12212529 · Cited by 6
Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies
Khan, S., & Bhat, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00010-2 · Cited by 6
Zhu, J. K., Song, S., Xu, X., Zhou, G., & Li, C. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13947 · Cited by 6
Niu, N., Wen-jun, Z., Xiao, B.-L., Liang, Y., Meng, X., Song, X.-Y., Li, D., Hong, J., & Moosavi‐Movahedi, A. A. (2021) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-021-02451-1 · Cited by 6
Ueno, Y., Kawamoto, Y., Nakane, Y., Natsume, R., Miura, K., Okumura, Y., Murate, T., Hattori, E., & Osawa, T. (2020) · Foods · doi:10.3390/foods9050538 · Cited by 6
Nitrooxidative Stress and Neurodegeneration
Fiedorowicz, M., & Grieb, P. (2012) · InTech eBooks · doi:10.5772/37733 · Cited by 6
Scuderi, S. A., Ardizzone, A., Casili, G., Mannino, D., Catalfamo, A., Lanza, M., & Esposito, E. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71006 · Cited by 6
Overexpression of Nrdp1/FLRF sensitizes cells to oxidative stress
Zhou, A., Pan, D., Yang, X., & Zhou, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.052 · Cited by 5
Current concepts on the etiology and pathogenesis of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5
Badae, N. M., Abdelmonsif, D. A., Aly, R. G. M., Omar, A. M., Shoela, M. S., & Omar, E. M. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12986 · Cited by 5
Humbert, M. S., Lewis, S., & Borgerding, A. J. (2021) · Talanta · doi:10.1016/j.talanta.2021.122599 · Cited by 4
Zuravski, L., Coelho, R. P., Duarte, J. A., Rocha, M. O., Mezzomo, J., Pilar, B. C., Galarça, L. L., Athayde, M. L., Boligon, A. A., Machado, M. M., et al. (2015) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2015.310006 · Cited by 4
Iwasaki, Y., Saito, H., Chen, K., Le-qi, H., Koshiishi, N., Mochizuki, K., Ito, R., & Akiyama, H. (2025) · Talanta · doi:10.1016/j.talanta.2025.128596 · Cited by 3
Gadhave, D. G., Kale, V. V., Kade, A. P., Jadhav, O. R., Sugandhi, V. V., Babar, V. B., Khot, S. V., Kokare, C., & Paudel, K. R. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103026 · Cited by 3
Metformin as a potential neuroprotective agent that influence Parkinson’s disease
Pal, B., Ghatak, N., & Hossain, C. M. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08370-w · Cited by 3
ASK1 and Its Role in Neurodegenerative Diseases
Sturchler, E., Feurstein, D., McDonald, P. H., & Duckett, D. R. (2011) · InTech eBooks · doi:10.5772/28950 · Cited by 3
EXPERIMENTAL ANIMAL MODELS OF PARKINSON’S DISEASE: AN OVERVIEW
Imran, M., Mishra, A., Usmani, A., & Eqbal, A. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i11.39131 · Cited by 3
Hassan, A. H. E., Choi, Y., Kim, R., Kim, H. J., Almatary, A. M., El‐Sayed, S. M., Lee, Y., Lee, J. K., Park, K. D., & Lee, Y. S. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117826 · Cited by 3
Biocompatibility, Metals Ions, and Corrosion Products
Tkaczyk, C., & Tabrizian, M. (2012) · ASM International eBooks · doi:10.31399/asm.hb.v23.a0005665 · Cited by 3
Kwon, H. J., Jung, H. Y., Yoo, D. Y., Moon, S. M., & Kim, D. W. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70324 · Cited by 2
Karagöz, Y. S., Doğan, Ö., Elgün, S., Öztop, D. B., & Kılıç, B. G. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01763-w · Cited by 2
Serum salusin-α and -β levels in patients with parkinson’s disease
Algül, F. E., Koç, E., & Tosun, H. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07031-0 · Cited by 2
Baghoori, D., Mehdi, R., Navid, M., Irani, A., & Alireza, A. B. (2016) · Scientific Journal of Rehabilitation Medicine · Cited by 2
Cheng, Y., Liu, C.-C., Chu, F., Yang, C., Hsiao, C., Chuang, C.-W., Shiau, M., Lee, H., Tsai, J., & Chang, Y.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155493 · Cited by 2
Razaghi, R., Piri, H., Jafari, H., Rastgoo, N., Hosseini, M. A., & Haghdoost-Yazdi, H. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.671.3 · Cited by 2
Mushrooms – From Traditional Remedies to the Modern Therapeutics
Stajić, M. M., Galić, M., & Ćilerdžić, J. L. (2023) · Springer eBooks · doi:10.1007/978-981-19-9550-7_5 · Cited by 2
Zhgenti, N., Bibilashvili, O., Burjanadze, G., Shengelia, M., & Koshoridze, N. (2023) · International Journal of Biochemistry and Biophysics · doi:10.13189/ijbb.2023.110301 · Cited by 2
A new subset of mitochondrial-derived vesicles perform inter-mitochondrial communications
Adla, P., Bshivakumar, V., Pathak, D., Mattam, U., Tammineni, P., Krishnamoorthy, T., & Sepuri, N. B. V. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e25-04-0188 · Cited by 1
Control of Autophagy in Parkinson’s Disease
González‐Polo, R. A., Gómez‐Sánchez, R., Pizarro‐Estrella, E., Yakhine-Diop, S. M. S., Rodríguez‐Arribas, M., & Fuentes, J. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_6 · Cited by 1
Talanov, S. A., Tkachenko, M. N., Bazilyuk, O. V., Stepanenko, L. G., & Sagach, V. F. (2009) · Neurophysiology · doi:10.1007/s11062-009-9096-x · Cited by 1
Biomarkers of Oxidative Stress in Parkinson’s Disease
Fernández‐Espejo, E. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00423 · Cited by 1
The Investigation of Lactoferrin Nitration: Quantification, Function, and Inhibition
Alhalwani, A. Y. (2018) · Digital Commons - DU (University of Denver) · Cited by 1
Jahromi, S. R. (2018) · International journal of basic science in medicine · doi:10.15171/ijbsm.2018.12 · Cited by 1
Antioxidant Activity of Food and By-Products: In Vitro Methods
Grosso, C., Moreira, M. M., Fernandes, V. C., Barroso, M. F., Silva, A., Delerue-Matos, C. M., & Soares, C. M. D. (2024) · Methods and protocols in food science · doi:10.1007/978-1-0716-3942-9_2 · Cited by 1
Absence of pretaporter restrains features of the parkin phenotype in Drosophila
Silvera, M. C., Cantera, R., & Ferreiro, M. J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114997 · Cited by 1
Sarbazi-Golezari, A., Haghdoost-Yazdi, H., & Minaei, A. (2020) · Physiology and Pharmacology · doi:10.32598/ppj.24.2.10 · Cited by 1
Neuroprotective effects of amantadine–flavonoid conjugates
Fourie, P. M. (2011) · Cited by 1
Mitochondrial Dysfunction and Protein Aggregation in the Cybrid Cell Model of Parkinson's Disease
Cronin-Furman, E. N. (2013) · doi:10.18130/v3dz3t · Cited by 1
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2012) · InTech eBooks · doi:10.5772/17669
Involvement of S-Nitrosylation in Neurodegeneration
Li, Y., & Chung, K. K. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_4
Self-citationWang, Y., Jiang, X., Liu, J., Zhao, M., Kang, G., Wu, J., Li, P., & Peng, S. (2011) · Molecular BioSystems · doi:10.1039/c1mb05037k
Iglesias, S. S. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Gama, S. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Isoforms of mammalian Glutaredoxin 2
Hudemann, C. (2009) · Figshare
Sophiabadi, M., Fraidouni, N., Faraji, A., Dargahi, T., Yaghubi-Dust, H., & Haghdoost-Yazdi, H. (2013)
Bassani, T. B. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Vieira, P. M. D. S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Neuroprotective Agents for Management of Parkinson’s disease
Kouti, L., Eslami, K., & Noroozıan, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
Fraidouni, N., Mohammad, S., Sophiabadi, M., & Haghdoost-Yazdi, H. (2012)
Regulation of the Inositol (1,4,5) Trisphosphate Receptor by Tumor Necrosis Factor-alpha
Park, K. M., Bowers, W. J., & Yule, D. I. (2009) · UR Research (University of Rochester)
Rola estrogenów w chorobie Parkinsona The role of estrogens in Parkinson's disease
Dziedziejko, V., Machoy‐Mokrzyńska, A., Kłodowska-Duda, G. A., & Chlubek, D. (2009)
Taram, F. (2016) · Digital Commons - DU (University of Denver)
Cook, N. L. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Hovsepyan, L., Ghazaryan, G., Zanginyan, H., & Zakaryan, G. (2017) · Brain and Nerves · doi:10.15761/jbn.1000101
The Effects of Sodium Hydrosulfide on Motor Learning in a Rat Model of Parkinson’s Disease
Esmaeili, M. H., Haghdoost-Yazdi, H., Abbasi, E., & Farshad, N. (2019) · The Journal of Qazvin University of Medical Sciences · doi:10.32598/jqums.22.6.106
Analyse von Tränenflüssigkeit als Biomarkerquelle beim idiopathischen Parkinsonsyndrom
Paul, H. L. J. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10491
Nahar, M., Rai, R., Khan, A. G., & Jat, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18716-2.00004-1
Pal, S., Si, S., Bindhani, B. K., Rao, G. N., & Pal, A. (2025) · DNA and cell biology reports. · doi:10.1177/29979811251362772
Neuroprotective effects of a biopeptidomimetic on an in vitro model
Babich, O., Тихонов, С. Л., Chernukha, I. M., Сухих, С. А., Тихонова, Н. В., & Сысуев, Е. Б. (2026) · Food systems · doi:10.21323/2618-9771-2026-9-1-4-13
Breaking the proteasome balance: α-synuclein and the ubiquitin-proteasome system
Ali, T. T., Popova, B., & Braus, G. H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1906331
Metadata
- Authors
- Tsang, A. H. K., & Chung, K. K. K.
- Affiliations
- Hong Kong University of Science and Technology (HK)
- Corresponding author
- Chung, Kenny K.K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 1792
- Issue
- 7
- Pages
- 643-650
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2093913750
- Cited by
- 300
- References
- 125
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 20 · 2016: 22 · 2015: 19 · 2014: 16 · 2013: 17 · 2012: 22
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Parkinson's disease, oxidative stress, nitrosative stress, dopaminergic neuron loss, protein nitration, lipid peroxidation, DNA damage, nitric oxide, S-nitrosylation, dopamine metabolism, neurodegeneration pathogenesis
- MeSH terms
- Animals, Humans, Nitric Oxide, Parkinson Disease, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review